Decoding the Silent Threat: Ischemic Heart Disease – A Pharmaceutical Imperative
Ischemic Heart Disease (IHD), commonly referred to as Coronary Artery Disease (CAD), continues to dominate global mortality statistics, representing the leading cause of death and disability worldwide. For pharmaceutical leaders like Taj Pharma India Limited, IHD is both a critical medical challenge and a compelling call to innovation. The disease’s…